In the latest Forbes' Wolfe Emerging Tech Report, Sanaria's new manufacturing facilities are featured as part of our efforts to develop a new vaccine against malaria.
News Categories
About Sanaria
Sanaria is a Maryland-based biotechnology company developing innovative vaccines that protect against malaria. We are focused on African children, the population most urgently in need of protection.
Latest News
Sanaria Participates in World Malaria Day Exhibition in Washington, DC
On May 6, 2026, Sanaria was honored to attend t...
Malaria No More Visits Sanaria
On Tuesday, May 5, 2026, Sanaria was honored to...
The Annual International PfSPZ Consortium Met in Toronto, Canada on November 8th & 9th, 2025
The 2025 iPfSPZ-C meeting brought together scienti...
Sanaria’s CEO, Dr. Stephen L. Hoffman awarded the Walter Reed Medal at the American Society of Tropical Medicine’s Annual Conference
The Walter Reed Medal is awarded every year to rec...
International PfSPZ Consortium Met in New Orleans on November 11th & 12th, 2024
On November 11th and 12th, 2024, the International...
